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SUMMARY – Reynolds Risk Score (RRS) is regarded as a good screening tool for cardiovascular 
disease (CVD) risk. Since CVD is the leading cause of death in Montenegro, we aimed to assess the 
risk of CVD as assessed by RRS and to examine its association with cardiometabolic parameters in 
apparently healthy middle-aged population. In addition, we aimed to test whether obesity had an in-
dependent infl uence on RRS. A total of 132 participants (mean age 56.2±6.73 years, 69% females) 
were included. Body mass index (BMI), waist circumference (WC), blood pressure (BP) and bio-
chemical parameters (fasting glucose, insulin, lipid parameters, creatinine and high sensitivity C-reac-
tive protein) were determined. Insulin resistance (HOMA-IR) and glomerular fi ltration rate (eGFR) 
were calculated. Compared with females, a signifi cantly higher number of males were in the high RRS 
subgroup (χ2=45.9, p<0.001). Furthermore, signifi cantly higher fasting glucose (p=0.030), insulin, 
HOMA-IR, triglycerides (p<0.001 all), anthropometric parameters (e.g., BMI and WC; p=0.004 and 
p<0.001, respectively), and creatinine, but lower eGFR and HDL-c (p<0.001 both) were recorded in 
the high-risk subgroup compared with low and medium risk subgroups. In all participants, in addition 
to LDL-c, diastolic BP and creatinine, WC was independently positively associated with RRS 
(β=0.194, p=0.006; β=0.286, p=0.001; β=0.267, p=0.001; and β=0.305, p=0.019, respectively), and 40% 
of variation in RRS could be explained with this model. In conclusion, middle-aged population with 
higher WC should be screened for RRS in order to estimate CVD risk.
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Introduction
Cardiovascular disease (CVD) is regarded as the 
leading cause of death in Montenegro, accounting for 
more than half of overall mortality (58.6%). Moreover, 
an increased prevalence of CVD has been reported in 
women (52.2%) compared with men (47.8%)1. Early 
detection of cardiovascular risk burden is of paramount 
importance for better targeting and treatment of indi-
viduals that are prone to CVD, as well as for prevent-
ing adverse cardiovascular outcomes2. In this sense, 
many algorithms for estimating CVD risk have been 
validated so far3,4.
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Th e fi rst Framingham Risk Score (FRS) included 
traditional risk factors (i.e. age, gender, total choles-
terol level (TC), high-density lipoprotein cholesterol 
level (HDL-c), systolic blood pressure (SBP), and 
whether the patient is treated or not for hypertension, 
diabetes, and smoking)5. It estimated the 10-year risk 
for coronary heart disease (CHD). Th e updated ver-
sion excluded diabetes because diabetes type 2 (DM2) 
was considered a CHD Risk Equivalent, having the 
same 10-year risk as individuals with prior CHD6.
On the other hand, infl ammation is regarded to be 
the underlying mechanism of atherosclerosis, from ath-
eroma formation, progression and destabilization of the 
plaque until its rupture4. Th erefore, the quest for bio-
markers of infl ammation which might add signifi cant 
contribution to CVD risk assessment has led to valida-
tion of another CVD risk score, e.g., Reynolds Risk 
Score (RRS). Namely, the mentioned score includes 
parental history of myocardial infarction or stroke7, as 
well as high sensitivity C-reactive protein (hsCRP) as 
the best validated infl ammation biomarker so far4.
Indeed, both RRS and FRS predict onset and pro-
gression of subclinical atherosclerosis8. However, RRS 
has been shown to improve CVD risk prediction com-
pared to FRS in both females and males8,9.
Similarly, many other population-based studies in 
subjects free of known CVD confi rmed the superiority 
of hsCRP above standard risk factors for risk predic-
tion10,11. On the contrary, hsCRP has been reported to 
contribute little to CVD risk prediction compared to 
traditional risk factors2. In addition, hsCRP was only 
mildly associated with carotid intima-media thickness 
in the absence of obesity12.
To our knowledge, there are no data on the use of 
RRS in CVD risk assessment among apparently healthy 
middle-aged population in Montenegro. Taking into 
account the high prevalence of CVD and mortality, we 
aimed to assess the CVD risk as estimated by RRS to 
examine its association with car diometabolic parame-
ters in middle-aged otherwise healthy Montenegrin 
population. In addition, we aimed to test whether obe-
sity had an independent infl uence on RRS.
Materials and Methods
Study population
Th is cross-sectional study enrolled 132 middle-
aged volunteers (mean age 56.2±6.73 years, 69% fe-
males). Th e subjects were recruited in the Primary 
Health Care Center in Podgorica, Montenegro, dur-
ing their regular check-up, in a period from March 
2013 to October 2013.
Th e criteria for inclusion in the study were as fol-
lows: volunteers without signs and symptoms of acute 
infl ammatory disease, with preserved kidney function 
(e.g., estimated glomerular fi ltration rate (eGFR) 
≥60 mL/min/1.73 m² and with urinary albumin excre-
tion (UAE) <30 mg/24 h), and who self-reported to be 
free of CVD, stroke and DM2. Parental history of 
myocardial infarction or stroke was obtained from 
each participant. Th e methods and assays used to ex-
clude participants and disorders have been described 
in detail elsewhere13.
All the participants provided their written informed 
consent. Th e study protocol was approved by the Ethics 
Committee of Primary Health Care Center in Podgori-
ca, Montenegro, and the research was carried out in 
compliance with the Declaration of Helsinki.
Anthropometric measurements
Basic anthropometric measurements including body 
height (cm), body weight (kg) and waist circumference 
(WC) (cm) were obtained, and body mass index (BMI) 
was calculated, as described elsewhere14. Blood pressure 
(BP) was measured as previously described14.
Reynolds Risk Score is based on age, gender, total 
cholesterol, HDL-c, smoking status, hsCRP level, fam-
ily history of heart attack in patient’s parents before the 
age of 60, and SBP. Th e RRS was calculated for each 
individual subject in accordance with the score sheet 
available as on-line calculator at: https://www.cvdrisk-
checksecure.com/ReynoldsRiskScore.aspx.
Th ereafter, the cohort of apparently healthy mid-
dle-aged population included in this study were di-
vided into low, medium and high risk subgroups (RRS 
<5%, 5%≤ RRS <10%, and RRS ≥10%, respectively)4.
Biochemical analyses
Biochemical parameters were measured as previ-
ously described13,14. Blood samples were collected be-
tween 7.00 and 9.00 a.m., 12-14 hours after an over-
night fast. Serum levels of glucose, creatinine, total 
cholesterol (TC), HDL-c, low density lipoprotein 
cholesterol (LDL-c) and triglycerides (TG) were mea-
sured using standardized enzymatic procedures, spec-
trophotometrically (Roche Cobas 400, Mannheim, 
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Germany). UAE was measured with turbidimetric as-
say (Roche Cobas 400, Mannheim, Germany). HsCRP 
levels were determined using an immunonephelomet-
ric assay (Behring Nephelometer Analyzer, BN II, 
Marburg, Germany). Insulin was measured by chemi-
luminescent immunometric assay (Immulite 2000, 
Siemens, Munich, Germany). Homeostasis assessment 
of insulin resistance (HOMA-IR) and eGFR were 
calculated as described in detail elsewhere14,15.
Statistical analysis
Th e SPSS statistical package (version 15.0 for 
Windows, SPSS, Chicago, IL, USA) was used for sta-
tistical analysis of the data, which were expressed as 
mean ± standard deviation or median (interquartile 
range), or counts and percentages. Diff erences between 
groups were examined by Student’s t test for normally 
distributed parameters, Mann-Whitney test for non-
normally distributed parameters, or one-way ANOVA, 
and Kruskal-Wallis non-parametric analysis of vari-
ance where appropriate. Th e χ2-test was used to exam-
ine diff erences between categorical data. Th e relation-
ship between RRS and other variables was evaluated 
by Pearson’s correlation coeffi  cient (r). Multiple linear 
regression analysis with enter selection procedure was 
performed to fi nd the independent factors aff ecting 
RRS and to estimate the fi nal predictors of its vari-
ability. Variables entered in the multiple linear regres-
sion model were normally distributed, showed signifi -
cant parametric correlation with RRS, and showed no 
multicollinearity. In all analyses, a p value <0.05 was 
considered as statistically signifi cant.
Results
Table 1 shows general clinical and biochemical 
characteristics of the study participants. Males dis-
played signifi cantly higher RRS. Th ey also showed sig-
Table 1. General characteristics of study participants
Characteristic Women (n=91) Men (n=41) p
Age (years) 56.8±6.15 54.9±7.80 0.150
BMI (kg/m²) 27.0±4.45 27.8±3.96 0.279 
WC (cm) 90.2±12.82 101±11.6 <0.001 
Fasting glucose (mmol/L) 5.40±0.38 5.56±0.41 0.029 
Insulin (μIU//L)# 6.36 (3.60-11.45) 7.60 (3.67-15.52) 0.187
HOMA-IR# 1.54 (0.87-2.76) 1.99 (0.92-3.95) 0.180
TC (mmol/L) 6.13±1.09 6.10±1.55 0.900
HDL-cholesterol (mmol/L)# 1.57 (1.32-1.93) 1.19 (0.88-1.37) <0.001 
LDL-cholesterol (mmol/L) 4.01±1.16 4.01±1.52 0.989
TG (mmol/L)# 1.21 (0.92-1.68) 1.93 (1.13-2.64) <0.001 
Non-HDL-c (mmol/L)# 4.29 (3.73-5.19) 4.40 (3.65-5.61) 0.545
TG/HDL-c ratio# 0.77 (0.49-1.16) 1.57 (0.92-2.79) <0.001
SBP (mm Hg) 134±16.7 140±13.8 0.031 
DBP (mm Hg) 84.1±11.39 88.2±9.03 0.322
Creatinine (μmol/L) 58.2±10.19 76.4±11.81 <0.001 
eGFR (mL/min/1.73 m²) 96.8±11.26 95.6±11.01 0.588
UAE (mg/24 h)# 6.07 (4.93-8.53) 6.65 (5.05-9.17) 0.521
hsCRP (mg/L)# 1.05 (0.51-2.24) 1.46 (0.76-1.78) 0.696
Family history, n (%) 17 (18.7) 13 (31.7) 0.156
RRS (%)# 2.00 (1.00-4.00) 10.00 (5.75-13.00) <0.001
Data are presented as mean ± standard deviation or #median (interquartile range); BMI = body mass index; WC = waist circumference; 
HOMA-IR = homeostasis model assessment of insulin resistance; TC = total cholesterol; HDL-cholesterol = high density lipoprotein 
cholesterol; LDL-cholesterol = low density lipoprotein cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood 
pressure; eGFR = estimated glomerular fi ltration rate; UAE = urinary albumin excretion; hsCRP = high sensitivity C-reactive protein; RRS 
= Reynolds Risk Score
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nifi cantly higher WC, fasting glucose, TG, TG/HDL-
ratio, creatinine and SBP, but lower HDL-c. Th ere was 
no diff erence in age, BMI, hsCRP and eGFR between 
the groups.
In the current study, we aimed to test the associa-
tion of cardiometabolic parameters (e.g., anthropo-
metric indices, lipid parameters, markers of insulin re-
sistance, renal function markers, and blood pressure) 
with the risk of CVD (as estimated using the RRS). A 
signifi cantly higher number of males were in the high-
er RRS subgroup as compared with females (χ2=45.9, 
p<0.001). Also, a signifi cantly higher number of over-
weight/obese individuals were in the high-risk sub-
group as compared with low-risk subgroup (χ2=5.11, 
p=0.024). Furthermore, we found signifi cant diff er-
ences in several parameters that are independent of 
RRS calculation, i.e. signifi cantly higher fasting glu-
cose level (p=0.030), insulin, HOMA-IR and TG 
(p<0.001 all), as well as in anthropometric parameters 
[e.g., BMI and WC (p=0.004, and p<0.001, respec-
tively)] in the high-risk subgroup. Moreover, we found 
signifi cantly higher creatinine, but lower HDL-c and 
eGFR in the high-risk subgroup as compared with 
low and medium risk subgroups (p<0.001). Th ere were 
Table 2. Cardiometabolic parameters in subgroups according to cardiovascular risk level





Age (years) 54.1±5.73aaa,bbb 58.9±6.68 59.7±7.16 <0.001
BMI (kg/m²) 26.2±4.46aa,bb 28.8±3.70 28.6±3.68 0.004
WC (cm) 88.1±11.85aaa,bbb 99.6±11.37 102.3±12.14 <0.001
Glucose (mmol/L) 5.37±0.39a 5.53±0.40 5.58±0.37 0.030
Insulin (μIU//L)# 5.00 (3.52-9.25)aaa,b 7.90 (4.50-15.65) 10.9(6.40-16.15) <0.001
HOMA-IR# 1.20 (0.79-2.28)aaa,b 1.99 (1.08-3.71) 2.85 (1.51-4.14) <0.001
TC (mmol/L) 5.92±1.07 6.42±0.92 6.37±1.81 0.099
HDL-c (mmol/L) 1.65±0.45aaa,b 1.40±0.45 1.20±0.38 <0.001
LDL-c (mmol/L) 3.80±1.10 4.30±1.06 4.31±1.76 0.085
TG (mmol/L)# 1.07 (0.89-1.36)aaa,bbb 1.71 (1.28-2.32) 1.96 (1.21-2.68) <0.001
Non-HDL-c (mmol/L) 4.27±1.08aa,bb 5.02±1.08 5.17±1.80 0.001
TG/HDL-c ratio# 0.68 (0.47-1.01)aaa,bbb 1.40 (0.82-2.09) 1.57 (1.07-2.58) <0.001
SBP (mm Hg) 129±14.9aaa,bbb 140±10.2a 149±15.1 <0.001
DBP (mm Hg) 81.1±10.0aaa,bbb 88.9±8.1a 93.7±9.43 <0.001
Creatinine (μmol/L) 59.7±12.50aaa 68.4±12.2aa 74.4±12.2 <0.001
eGFR (mL/min/1.73 m²) 98.7±10.03 94.3±14.44 92.1±8.99 0.013
UAE (mg/24 h)# 5.92 (4.91-7.39)b 7.82 (5.11-9.80) 6.96 (4.94-10.28) 0.091
hsCRP (mg/L) 0.80 (0.42-1.86)aaa,b 1.50 (0.56-2.75) 1.76 (1.43-2.91) <0.001
RRS (%) 1.79±1.15aaa,bbb 6.00±1.14aaa 14.21±5.30 <0.001
Overweight/obese, n (%) 39 (50) 20 (74) 20 (71) χ
2=5.11
0.024
Normal weight, n (%) 38 (49.4) 7 (26) 8 (29)
Gender (F/M), n (%) 69/8 (76/19) 16/11 (18/27) 6/22 (6/54) χ2= 45.9
<0.001
ap<0.05; aap<0.01; aaap<0.001 vs. high RRS; bp<0.05; bbp<0.01; bbbp<0.001 vs. medium RRS; RRS = Reynolds Risk Score; #data with non-
gaussian distribution are shown as median values (interquartile range); *p value from one-way ANOVA or Kruskal-Wallis non-parametric 
analysis of variance, followed by non-parametric Mann-Whitney U test, where appropriate; BMI = body mass index; WC = waist circum-
ference; HOMA-IR = homeostasis model assessment of insulin resistance; TC = total cholesterol; HDL-c = high density lipoprotein 
cholesterol; LDL-c = low density lipoprotein cholesterol; TG = triglycerides; SBP = systolic blood pressure; DBP = diastolic blood pressure; 
eGFR = estimated glomerular fi ltration rate using the Chronic Kidney Disease Epidemiology Collaboration Equation; UAE = urinary 
albumin excretion; hsCRP = high sensitivity C-reactive protein; F = female; M = male
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no gender diff erences in the prevalence of parental his-
tory of myocardial infarction or stroke (Table 2).
Th ereafter, we performed Pearson’s parametric cor-
relation to examine the potential relationship between 
RRS and cardiometabolic parameters normally dis-
tributed and independent of RRS calculation. RRS 
correlated positively with anthropometric parameters 
(BMI and WC), fasting blood glucose, lipid parame-
ters (LDL-c and non-HDL-c), as well as with creati-
nine concentrations. RRS negatively correlated with 
the renal function marker (eGFR) (Table 3).
Multiple linear regression analysis was performed 
to explore which of the measured markers had the best 
association with RRS. All variables found to have a 
signifi cant predictive value in Pearson’s parametric 
correlation analysis (BMI, WC, glucose, LDL-c, cre-
atinine and DBP) were further analyzed in multiple 
linear regression analysis for RRS prediction. Non-
HDL-c and eGFR were excluded from further analy-
sis due to multicollinearity. With enter selection pro-
cedure, the best model consisted of 6 parameters (Ta-
ble 4). Th ese 6 independent variables statistically sig-
nifi cantly predicted RRS in the good-fi t data model, F 
(6,125)=15.364, p<0.001. Namely, WC, LDL-c, DBP 
and creatinine were independently positively associat-
ed with RRS (β=0.305, p=0.019; β=0.194, p=0.006; 
β=0.286, p=0.001; β=0.267 and p=0.001, respectively). 
Adjusted R2 for the best-fi t model was 0.40, which 
means that 40% of variation in RRS could be explained 
with this model, for all participants. Th e parameters of 
multiple regression analysis, unstandardized coeffi  -
cient (B), its standard error (SE), standardized coef-
fi cient (β), t value and signifi cance (p) are shown in 
Table 4.
Discussion
In the current study, we assessed cardiovascular risk 
as determined by RRS in apparently healthy middle-
aged population in Montenegro. Our fi ndings revealed 
that even 41.7% of them had medium or high CVD 
Table 3. Pearson’s correlation coeffi  cient (r) of Reynolds 
Risk Score (RRS) with study parameters independent 
of RRS calculation in all participants
Variable r p
BMI (kg/m²) 0.298 0.001
WC (cm) 0.470 <0.001
Fasting glucose (mmol/L) 0.282 0.001
LDL-c (mmol/L) 0.201 0.021
Non-HDL-c (mmol/L) 0.313 <0.001
DBP (mm Hg) 0.463 <0.001
Creatinine (μmol/L) 0.465 <0.001
eGFR (mL/min/1.73 m²) -0.282 0.001
BMI = body mass index; WC = waist circumference; LDL-c = low 
density lipoprotein cholesterol; non-HDL-c = non-high density 
lipoprotein cholesterol; DBP = diastolic blood pressure; eGFR = 
estimated glomerular fi ltration rate using the Chronic Kidney Dis-
ease Epidemiology Collaboration Equation
Table 4. Multiple regression analysis for the association of study parameters 
with Reynolds Risk score (RRS)






B Standard error β t p
BMI (kg/m2) -0.211 0.153 -0.163 -1.375 0.172
WC (cm) 0.127 0.053 0.305 -2.380 0.019
Fasting glucose (mmol/L) 1.722 1.038 0.122 1.659 0.100
LDL-c (mmol/L) 0.847 0.300 0.194 2.821 0.006
DBP (mm Hg) 0.147 0.041 0.286 3.574 0.001
Creatinine (μmol/L) 0.109 0.032 0.267 3.365 0.001
BMI = body mass index; WC = waist circumference; LDL-c = low density lipoprotein cholesterol; DBP = dia-
stolic blood pressure
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risk (20.5% and 21.2%, respectively). Moreover, men 
displayed a signifi cantly higher CVD risk than wom-
en, accounting for more than half of males with higher 
RRS (even 54%), as compared with males with low 
and intermediate risk (19% and 27%, respectively) 
(Table 2). Our results are in agreement with other 
studies, which also reported signifi cantly higher CVD 
risk in males compared to females16,17.
Indeed, both the FRS and the RRS stratify a large 
number of women to the low-risk category (e.g., 76% 
of women were stratifi ed in the low CVD risk in the 
current study), raising doubts that they may not accu-
rately defi ne an individual’s lifetime risk3. However, 
RRS has been shown to improve CVD risk prediction 
compared to FRS in both females and males9.
In our study, there was no diff erence in serum 
hsCRP level between males and females (Table 1), al-
though discrepant results have been reported in other, 
larger studies18,19. Cushman et al.20 in their national 
study showed that RRS classifi ed the population dif-
ferently than FRS. Namely, almost 50% of the exam-
ined women had increased hsCRP (e.g., >3 mg/L) and 
were more likely to have this infl ammation biomarker 
increased despite the much lower FRS. DeFilippis et 
al.8 in the Multi-Ethnic Study of Atherosclerosis 
showed that RRS added additional predictive power 
for subclinical atherosclerosis incidence and progres-
sion, when there was discrepancy between FRS and 
RRS. Pietka et al.21 in a cohort of 119 non-diabetic 
men with stable coronary artery disease and preserved 
left ventricular systolic function showed that men with 
higher RRS had lower frequency of marginal or no 
atherosclerotic coronary arteries.
On the other hand, several studies report that 
hsCRP has only a minor contribution to CVD risk 
prediction compared to traditional risk factors2,22. In 
the JUPITER study that included 6760 participants, 
Blaha et al.12 report that hsCRP was not associated 
with subclinical atherosclerosis, using coronary artery 
calcium and was mildly associated with carotid inti-
ma-media thickness in the absence of obesity. On the 
contrary, obesity was associated with both indicators of 
subclinical atherosclerosis independently of hsCRP 
level.
Obesity itself is believed to contribute to low-grade 
infl ammation, as adipose tissue has been found to se-
crete a great variety of proinfl ammatory adipocyto-
kines. Moreover, abdominal body fat distribution has 
more atherogenic properties than overall adiposity23,24. 
It is important to note that although we included in 
our study only apparently healthy participants free of 
diabetes and CVD, the majority of them were found to 
be overweight/obese and were stratifi ed in the inter-
mediate or higher CVD risk group (74% and 71%, re-
spectively) (Table 2).
Th e results obtained in the current study showed 
that besides traditional cardiometabolic parameters 
such as high LDL-c, DBP and creatinine, WC was 
independently associated with RRS (Table 4). Th ese 
fi ndings may support the important link between obe-
sity and CVD, and are in accordance with our previous 
studies conducted in adolescent girls25,26 and post-
menopausal women1,27. However, the results of the 
current study extended our previous fi ndings, suggest-
ing that the independent association between obesity 
and increased CVD risk existed in both genders. Fur-
thermore, since FRS that includes traditional CVD 
markers may underestimate CVD risk28, we assessed 
RRS, taking into account that infl ammation may add 
signifi cant contribution to the increased CVD risk 
burden25,29.
Other studies report similar results. Su et al.16 in a 
study on 882 Malays found WC to correlate strongly 
with CVD risk in both males and females. In the Fili-
pino-American Women Cardiovascular Study, An-
cheta et al.30 showed that increased WC was associated 
with increased CVD risk scores, suggesting the need 
for obesity control as primary prevention of CVD. In-
deed, Karam et al.17 during campaigns for reducing 
CVD incidence showed that over a 6-year period, sev-
eral CVD risk factors had decreased, leading to a de-
crease in the 10-year risk of CVD. Goh et al.31 in a 
representative sample of almost 4500 Australian wom-
en aged 20-69 years without CVD, diabetes or stroke 
report that abdominal obesity measures were better 
predictors of CVD risk compared with overall obesity 
measures. Similarly, Park et al.32 report on WC to be a 
more predictive marker of coronary artery calcifi cation 
than BMI. Pokharel et al.33 report on positive associa-
tion of both BMI and WC with subclinical atheroscle-
rosis.
On the contrary, in a recent study on 610 healthy 
Iranian adults, Salari et al.34 report no independent as-
sociation between obesity indices and atherosclerosis. 
In addition, results of a cross-sectional study on 120 
subjects undergoing coronary angiography showed 
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that anthropometric measurements could not be 
markers of atherosclerosis in subjects with overweight/
obesity35.
Despite discrepant results reported from diff erent 
studies and many novel biomarkers for CVD risk as-
sessment having been investigated so far, it seems that 
traditional cardiometabolic markers (e.g., LDL-c, 
DBP, creatinine), and especially obesity indices (e.g., 
WC) must not be underscored. Th us, strategies for re-
ducing obesity may be of great importance in decreas-
ing CVD risk.
Th e current study had some limitations. A relative-
ly small number of participants may be a limiting fac-
tor when dealing with CVD risk estimation. Th erefore, 
a national-representative sample study should confi rm 
these results. Moreover, since only apparently healthy 
middle-aged subjects were included, the prevalence of 
increased CVD risk in Montenegrin population might 
be even higher. Furthermore, prospective studies are 
needed to confi rm the causal link between increased 
CVD risk and obesity, and what is more important, to 
include prediction of cardiovascular events.
Nevertheless, a signifi cantly high prevalence of 
overweight/obese individuals who were stratifi ed in 
the intermediate and high CVD risk groups and the 
independent relationship between RRS and WC ob-
served in the current study may indicate an urgent 
need for developing strategies to reduce obesity and 
hence the CVD risk, morbidity and mortality as well.
Conclusion
In the middle-aged study population, in addition 
to LDL-c, diastolic BP and creatinine, WC was inde-
pendently positively associated with RRS. In addition, 
even though many novel biomarkers for CVD risk as-
sessment have been investigated so far, it seems that 
traditional cardiometabolic markers, especially obesity 
indices, must not be underscored. Th us, strategies for 
reducing obesity may be of great importance in de-
creasing CVD risk in primary prevention setting.
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Sažetak
KARDIOVASKULARNI RIZIK PROCIJENJEN REYNOLDSOVIM ZBIROM RIZIKA 
U ODNOSU NA OBIM STRUKA U POPULACIJI ODRASLIH ZDRAVIH CRNOGORACA
A. Klisić, N. Kavarić, B. Bjelaković, M. Jovanović, E. Zvrko, V. Stanišić, A. Ninić i A. Šćepanović
Reynoldsov zbir rizika (Reynolds Risk Score, RRS) se smatra dobrim algoritmom probira za procjenu rizika od kardiova-
skularnih bolesti (KVB). Kako su KVB vodeći uzrok smrtnosti u Crnoj Gori, cilj studije je bio procijeniti KV rizik primje-
nom algoritma RRS i ispitati njegovu povezanost s kardiometaboličkim čimbenicima rizika u populaciji odraslih zdravih 
ispitanika. Cilj je također bio ispitati nezavisan utjecaj pretilosti na RRS. U studiju su bile uključene 132 osobe srednje dobi 
od 56,2±6,73 godine; 69% su bile žene. Mjereni su sljedeći parametri: indeks tjelesne mase, obim struka, krvni tlak te bioke-
mijski parametri (glikemija natašte, inzulin, lipidni parametri i visoko osjetljiv C-reaktivni protein). Izračunata je inzulinska 
rezistencija (HOMA-IR) i procijenjena razina glomerularne fi ltracije (eGFR). U usporedbi sa ženama, značajno veći broj 
muškaraca bio je u skupini s većim KV rizikom (χ2=45,9; p<0,001). Također, značajno veće vrijednosti glikemije natašte 
(p=0,030), inzulina (p<0,001), HOMA-IR (p<0,001), triglicerida (p<0,001), antropometrijskih parametara [npr. indeks tje-
lesne mase (p=0,004) i obim struka (p<0,001)] i kreatinina (p<0,001), a niže vrijednosti eGFR (p<0,001) i HDL-c (p<0,001) 
uočene su u podskupini s većim KV rizikom u usporedbi s podskupinama s niskim i srednjim rizikom (p<0,001). Uz vrijed-
nosti LDL-c (β=0,194, p=0,006), dijastoličkog krvnog tlaka (β=0,286, p=0,001) i kreatinina (β=0,267, p=0,001), obim struka 
je bio nezavisno povezan s RRS (β=0,305, p=0,019); 40% varijabilnosti u RRS moglo se objasniti ovim modelom. U zaključ-
ku, populaciji ispitanika srednje dobi s povećanim obimom struka treba odrediti RRS radi procjene rizika od KVB.
Ključne riječi: Kardiovaskularne bolesti; Rizični čimbenici; Indeks tjelesne mase; Struk, obim; C-reaktivni protein; Pretilost; 
Uzrok smrti; Crna Gora
